AnGes Submits Application for Marketing Approval to PMDA for HGF gene therapy for Critical Limb Ischemia – GlobeNewswire (press release)
|
AnGes Submits Application for Marketing Approval to PMDA for HGF gene therapy for Critical Limb Ischemia
GlobeNewswire (press release) TOKYO, Jan. 23, 2018 (GLOBE NEWSWIRE) — AnGes, Inc., a biopharmaceutical company focused on developing innovative gene-based medicines for serious diseases, announced today the submission of an application for marketing approval to the Pharmaceuticals … |
